Mergers & AcquisitionsMedium•4 November 2026•
1 min read
DataMeds AI Terminates Merger Letter of Intent with Datavault AI Citing Market Conditions
Key Facts
1DataMeds AI, Inc. has terminated its second amended and restated letter of intent with Datavault AI Inc.
2The termination was attributed to market conditions, resulting in no issuance of shares related to the proposed transaction.
DataMeds AI, Inc. has terminated its second amended and restated letter of intent with Datavault AI Inc. Benzinga reported that the company attributed the termination to current market conditions, resulting in the cancellation of the share issuance previously planned for the transaction.
MEDS closed at $1.80 on November 3, 2026, while DVLT closed at $0.0727 on the same date. The decision to halt the merger discussions follows a period of market volatility, though DataMeds AI noted that certain existing operational licenses and smart contract agreements with Datavault AI remain in effect despite the deal termination.